Tenderwize
Zurück zur Suche

Non-exclusive discount contracts for drugs with active substance iron(III) sodium gluconate complex (B03AC07) under an open-house model

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Sep 30, 2026 · 35 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Eisen(III)natrium-Gluconat-Komplex (B03AC07) im Rahmen eines sogenannten Open-House-Modells.

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

40 / 100

Komplexität

20 / 100

Risikofaktoren

The buyer reserves the right to replace open-house contracts with exclusive discount contracts during the term, leading...

No estimated value, volume, or pricing information is provided; potential revenue is unknown.

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Nov 2026
  • Conclusion of non-exclusive discount contracts for drugs with active substance iron(III) sodium gluconate complex (B03AC07)
  • Contracts are open to all pharmaceutical companies with authorized and marketable products in Germany
Vollständige Zusammenfassung anzeigen

Open-house model for non-exclusive discount contracts for pharmaceutical products with active substance iron(III) sodium gluconate complex (B03AC07). The AOK Rheinland-Pfalz/Saarland invites all interested pharmaceutical companies to conclude uniform, non-negotiable discount contracts on a first-come, first-served basis. Contracts run for a maximum of 24 months from December 2024. The notice is published for transparency and is not a standard public procurement procedure.

Risiken

The buyer reserves the right to replace open-house contracts with exclusive discount contracts during the term, leading...

No estimated value, volume, or pricing information is provided; potential revenue is unknown.

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Proof of marketability via listing in Lauer-Taxe or AMIce database

Eligibility

  • Only drugs that are authorized and marketable in Germany are eligible

Administrative

  • Submission of signed contract documents and required annexes by specified deadlines

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No explicit award criteria; all eligible applicants are accepted.

Auftraggeber

Lose (1)

LOT-0000

Non-exclusive discount contracts for drugs with active substance iron(III) sodium gluconate complex (B03AC07) under an open-house model

Non-exclusive discount contracts for the active substance B03AC07. All interested pharmaceutical companies with authorized and marketable drugs in Germany can join. Uniform terms, no individual negotiations. Contracts can start monthly from December 2024 until November 2026.

SuppliesEU fundedElectronic submission

Ort

DEB3D, Germany

Dauer

Nov 2024 - Nov 2026

Kategorie

Pharmaceutical products

Zuschlagskriterien

No explicit award criteria; all eligible applicants are accepted.

Frist

Deadline Sep 30, 2026

Vergabedetails

Veröffentlichungsdatum
10 Oct 2024
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
615563-2024

Dokumente (1)

Ähnliche Ausschreibungen